Cyclin-dependent kinase inhibitor 2A (CDKN2A) is an essential cell cycle regulating factor, and a study found that the absence of CDKN2A promoted the progression of lung cancer and that it was correlated with poor survival26. The gene discussed is CDKN2A; the disease is lung carcinoma.